Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen

Eur J Dermatol. 2019 Dec 1;29(6):667-669. doi: 10.1684/ejd.2019.3668.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Alopecia Areata / drug therapy*
  • Cost Savings*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Piperidines / administration & dosage*
  • Piperidines / economics*
  • Protein Kinase Inhibitors / administration & dosage*
  • Pyrimidines / administration & dosage*
  • Pyrimidines / economics*
  • Pyrroles / administration & dosage*
  • Pyrroles / economics*
  • Severity of Illness Index
  • Treatment Outcome
  • Young Adult

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Pyrroles
  • tofacitinib